L
Lukas Raab
Researcher at Graz University of Technology
Publications - 4
Citations - 101
Lukas Raab is an academic researcher from Graz University of Technology. The author has contributed to research in topics: Cache & Vaccination. The author has an hindex of 2, co-authored 2 publications receiving 53 citations.
Papers
More filters
Posted Content
Nethammer: Inducing Rowhammer Faults through Network Requests
Moritz Lipp,Misiker Tadesse Aga,Michael Schwarz,Daniel Gruss,Clémentine Maurice,Lukas Raab,Lukas Lamster +6 more
TL;DR: This paper presents Nethammer, a remote Rowhammer attack without a single attacker-controlled line of code on the targeted system, i.e., not even JavaScript, and invalidates threat models of Rowhammer defenses building upon the assumption of a local attacker.
Proceedings ArticleDOI
Nethammer: Inducing Rowhammer Faults through Network Requests
Moritz Lipp,Michael Schwarz,Lukas Raab,Lukas Lamster,Misiker Tadesse Aga,Clémentine Maurice,Daniel Gruss +6 more
TL;DR: In this article, a remote Rowhammer attack without a single attacker-controlled line of code on the targeted system, i.e., not even JavaScript, is presented, which works on commodity consumer-grade systems that either are protected with quality-of-service techniques like Intel CAT or use uncached memory, flush instructions, or non-temporal instructions while handling network requests.
Journal ArticleDOI
Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial
Andreas Heinz,Eva Schrezenmeier,Florina Regele,Karin Hu,Lukas Raab,Michael Uder,Christof Aigner,Rhea Jabbour,Constantin Aschauer,Ana-Luisa Stefanski,Thomas Dörner,Klemens Budde,Roman Reindl-Schwaighofer,Rainer Oberbauer +13 more
TL;DR: Despite a similar overall seroconversion rate at 3 months following 3rd vaccination in KTR, a heterologous 3rd booster vaccination with Ad26COVS1 resulted in significantly higher antibody levels in responders.
Journal ArticleDOI
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
Andreas Heinz,Eva Schrezenmeier,Florina Regele,Karin Hu,Lukas Raab,Michael Uder,Christof Aigner,Rhea Jabbour,Constantin Aschauer,Ana-Luisa Stefanski,Thomas Dörner,Klemens Budde,Roman Reindl-Schwaighofer,Rainer Oberbauer +13 more
TL;DR: This work presents a novel, scalable and scalable approach that allows for real-time measurement of the response of the immune system to treat central nervous system injuries.